In osteosarcoma cells (MNNG/HOS, U2OS), lncRNA MALAT1 overexpression suppresses p53 and miR-34c, activating survival pathways through Myc and SOX4, which promote drug resistance [15]. Here, TP53 is linked to osteosarcoma.